UNITY Biotechnology, Inc. to Participate in the 2019 Cantor Global Healthcare Conference
A live audio webcast of the presentation will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following the event.
UNITY is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter.
Investors Endurance Advisors
Peter Rahmerprahmer@enduranceadvisors.com Media Jason Sparkjason@canalecomm.com
Source: Unity Biotechnology, Inc.